MOSCOW, Nov. 30, 2021 /PRNewswire/ -- RUSAL
(SEHK: 486, Moscow Exchange: RUAL), a leading global aluminium
producer, has donated $105 million
(eight billion Russian Rubles) to combat COVID-19 and support
regional healthcare systems across Russia in the fight against the pandemic.
RUSAL has funded seven emergency medical centres in Siberia and the Urals which opened one year
ago to treat patients suffering with COVID-19 and pneumonia. The
Company donated over $52 million
(four billion Russian Rubles) to construct the centres including
all equipment required to treat patients such as computer
tomographs, high-tech ultrasound devices, oxygen stations,
laboratory and functional diagnostics devices.
Despite the complexity and scale of building the medical
centres, construction was completed within just seven months. Since
opening, medical professionals have treated over 13,500 people.
RUSAL continued to finance measures to combat the pandemic,
including providing regular support to regional healthcare systems.
The Company has allocated an additional $52
million (four billion Russian Rubles) towards ongoing
initiatives comprising the provision of medicines and reagents for
laboratories, personal protective equipment, ambulances for
regional hospitals and oxygen concentrators which are necessary for
the treatment of patients in a serious condition. RUSAL has also
organized online seminars with leading experts for medical
personnel, providing them with the latest information on advanced
methods for treating COVID-19.
Providing financial and practical medical support to regional
healthcare systems, which often lack the facilities found in major
cities, is an initiative developed by RUSAL. The need for such
essential health services in remote regions has become even more
crucial against the backdrop of a global pandemic.
RUSAL's General Director Evgenii Nikitin
said:
"RUSAL is one of the first Russian companies to launch a
full-scale healthcare support programme to tackle the COVID-19
pandemic. Our experience of providing critical medical facilities
in Guinea to fight the Ebola
epidemic prepared us well to address the urgent healthcare
facilities we now need in Russia,
especially in small, remote cities where there is often a lack of
access to the latest medical equipment.
"RUSAL has donated more than $105
million (eight billion Russian Ruble) in the fight against
COVID-19 since March 2020. But it is
much more than a financial contribution – this is about creating a
lasting legacy of giving back to those communities across the globe
which really matter to us and providing care to the people who need
it most."
About RUSAL
RUSAL (www.rusal.com) is a leader in the global aluminium
industry and a leading low-carbon aluminium producer. In 2020, the
Company accounted for about 5.8% of global production of aluminium,
6.5% of alumina production and 44% of RUSAL's production accounts
for value added products. RUSAL's offices are operating in 20
countries all over the world and across 5 continents. The carbon
footprint of the Company's low-carbon aluminium ALLOW is 5 times
lower than the industry's average (Scope 1 and 2, at the smelter).
RUSAL common stock is traded on the Hong Kong Stock Exchange (trade
code – 486). RUSAL's ordinary shares are traded on the Moscow
Exchange (trade code – RUAL).
Disclaimer
The information contained in this press release is for
media advice only. The contents are true and accurate at the time
of publishing, however, may change over time.
Photo -
https://mma.prnewswire.com/media/1698962/Achinsk_medical_centre_RUSAL.jpg